Scoop has an Ethical Paywall
Licence needed for work use Learn More
Parliament

Gordon Campbell | Parliament TV | Parliament Today | Video | Questions Of the Day | Search

 

PHARMAC's role in breast cancer drug debate

Monday, 13 February 2006

Dunne queries PHARMAC's role in breast cancer drug debate

Associate Health Minister and United Future leader Peter Dunne is querying the conflicting role being played by the Government's drug-buying agency, PHARMAC, in the debate over whether the breast cancer drug, Herceptin, should be subsidised more widely.

At present, PHARMAC subsidises the drug for women in the final stages of breast cancer and is querying research which shows it is beneficial for women in the early stages of the illness as well.

"This means" says Mr Dunne "that PHARMAC is making a clinical decision on the drug and is then using that decision to make the funding choice.

"This is a confusion of roles that I am not convinced is in the best interests of the people of New Zealand.

"That's why United Future included in its confidence and supply agreement with Labour the view that a national medicines strategy be developed and the role of PHARMAC in that strategy be reviewed," said Mr Dunne.

ENDS


Advertisement - scroll to continue reading

© Scoop Media

Advertisement - scroll to continue reading
 
 
 
Parliament Headlines | Politics Headlines | Regional Headlines

 
 
 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 
 

Featured News Channels


 
 
 
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.